Researchers studied RNA from tumors of premenopausal women with HR-positive breast cancer.
Index can predict which premenopausal women with hormone receptor–positive breast cancer benefit from ovarian function suppression therapy. Women with BCIResearchers conducted a prospective-retrospective translational study using tumor tissue samples from 1718 premenopausal women with hormone receptor–positive early-stage breast cancer .
The primary endpoints were breast cancer–free interval and distant recurrence-free interval , with a median follow-up time of 12 years.
Malignant Breast Neoplasm Breast Carcinoma Ob/Gyn And Women's Health Nursing Womens Health Women's Health Tamoxifen Selective Estrogen Receptor Modulators SERM - Selective Estrogen Receptor Modulator Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Breast Mammary Gland Tumor Aromatase Inhibitor Exemestane Receptors Healthcare And Medical Technology
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Early detection blood test for breast cancer being developed by Michell Cancer InstituteResearchers at the USA Health Mitchell Cancer Institute are developing a blood test for an aggressive subtype of breast cancer.The test is for early detection a
Read more »
US Dollar Index remains below 104.50 as traders await the US PCE Price IndexThe US Dollar Index (DXY), which measures the value of the US Dollar (USD) against six other major currencies, retraces its recent gains ahead of the release of the US Personal Consumption Expenditures (PCE) Price Index for June.
Read more »
Artera Launches AI Test for Decision-making on Prostate Cancer Treatment CourseA new AI test predicts the progression of prostate cancer and treatment benefits.
Read more »
Black Women With Breast Cancer Face Clinical InequitiesA study found Black metastatic breast cancer patients with PIK3CA mutations were less likely to receive targeted therapy or join trials than White patients.
Read more »
Double Mastectomy May Offer No Survival Benefit to Women With Breast CancerWomen who are diagnosed with breast cancer in one breast, even in the early stages, sometimes opt for a double mastectomy, due to the fear that the cancer will migrate to the other breast.
Read more »
MetroHealth offering mammograms at some Discount Drug Mart locationsBreast cancer screening can help find breast cancer early, when it is easier to treat. Women who are 40 to 74 years old and are at average risk for breast cancer should get a mammogram every two years, according to the CDC
Read more »